| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urinary Bladder, Neurogenic | 46 | 2021 | 161 | 7.710 |
Why?
|
| Urodynamics | 69 | 2021 | 360 | 7.640 |
Why?
|
| Urinary Bladder | 61 | 2021 | 1134 | 4.960 |
Why?
|
| Urinary Incontinence | 36 | 2021 | 459 | 4.020 |
Why?
|
| Urination Disorders | 22 | 2018 | 246 | 3.030 |
Why?
|
| Meningomyelocele | 22 | 2012 | 166 | 2.610 |
Why?
|
| Urethra | 32 | 2020 | 409 | 2.400 |
Why?
|
| Vesico-Ureteral Reflux | 39 | 2022 | 422 | 2.230 |
Why?
|
| Urinary Tract | 20 | 2022 | 293 | 2.160 |
Why?
|
| Urinary Bladder Diseases | 17 | 2016 | 174 | 1.710 |
Why?
|
| Neural Tube Defects | 12 | 2017 | 248 | 1.690 |
Why?
|
| Urologic Diseases | 7 | 2016 | 252 | 1.660 |
Why?
|
| Intermittent Urethral Catheterization | 2 | 2022 | 9 | 1.520 |
Why?
|
| Botulinum Toxins, Type A | 3 | 2021 | 199 | 1.480 |
Why?
|
| Urogenital Abnormalities | 9 | 2022 | 247 | 1.400 |
Why?
|
| Spinal Dysraphism | 6 | 2017 | 151 | 1.400 |
Why?
|
| Urology | 6 | 2015 | 371 | 1.360 |
Why?
|
| Urinary Bladder, Overactive | 5 | 2021 | 101 | 1.190 |
Why?
|
| Nocturnal Enuresis | 4 | 2019 | 12 | 1.190 |
Why?
|
| Diagnostic Techniques, Urological | 4 | 2015 | 27 | 1.160 |
Why?
|
| Fecal Incontinence | 5 | 2015 | 221 | 1.150 |
Why?
|
| Ureter | 15 | 2016 | 363 | 0.990 |
Why?
|
| Neuromuscular Agents | 2 | 2021 | 140 | 0.970 |
Why?
|
| Child | 171 | 2022 | 74147 | 0.960 |
Why?
|
| Urination | 13 | 2022 | 199 | 0.760 |
Why?
|
| Losartan | 1 | 2021 | 265 | 0.720 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2021 | 470 | 0.650 |
Why?
|
| Defecation | 3 | 2017 | 172 | 0.640 |
Why?
|
| Constipation | 5 | 2015 | 495 | 0.620 |
Why?
|
| Child, Preschool | 109 | 2020 | 41183 | 0.600 |
Why?
|
| Urinary Catheterization | 11 | 2015 | 193 | 0.560 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2019 | 603 | 0.530 |
Why?
|
| Terminology as Topic | 5 | 2015 | 1622 | 0.530 |
Why?
|
| Spinal Cord | 11 | 2017 | 1821 | 0.510 |
Why?
|
| Cerebral Palsy | 3 | 2017 | 432 | 0.500 |
Why?
|
| Fibrosis | 1 | 2021 | 1944 | 0.500 |
Why?
|
| Varicocele | 6 | 2015 | 74 | 0.480 |
Why?
|
| Urethral Diseases | 4 | 2018 | 54 | 0.470 |
Why?
|
| Infant | 85 | 2020 | 34497 | 0.470 |
Why?
|
| Neurogenic Bowel | 1 | 2012 | 1 | 0.470 |
Why?
|
| Ureteral Obstruction | 11 | 2011 | 300 | 0.460 |
Why?
|
| Glycopeptides | 1 | 2013 | 208 | 0.450 |
Why?
|
| Digestive System Abnormalities | 1 | 2012 | 45 | 0.450 |
Why?
|
| Urologic Surgical Procedures | 5 | 2016 | 293 | 0.450 |
Why?
|
| Syringomyelia | 1 | 2012 | 73 | 0.430 |
Why?
|
| Biofeedback, Psychology | 2 | 2009 | 111 | 0.420 |
Why?
|
| Writing | 1 | 2013 | 196 | 0.420 |
Why?
|
| Kidney | 23 | 2022 | 6903 | 0.420 |
Why?
|
| Antidiuretic Agents | 2 | 2012 | 24 | 0.410 |
Why?
|
| Urography | 11 | 2016 | 326 | 0.410 |
Why?
|
| Humans | 227 | 2022 | 715118 | 0.410 |
Why?
|
| Adolescent | 92 | 2022 | 85001 | 0.400 |
Why?
|
| Mandelic Acids | 4 | 1999 | 50 | 0.390 |
Why?
|
| Deamino Arginine Vasopressin | 2 | 2012 | 98 | 0.390 |
Why?
|
| Intestines | 5 | 2017 | 1934 | 0.390 |
Why?
|
| Quality of Life | 5 | 2017 | 11691 | 0.380 |
Why?
|
| Urinary Sphincter, Artificial | 2 | 2008 | 29 | 0.380 |
Why?
|
| Diverticulum | 4 | 2009 | 133 | 0.360 |
Why?
|
| Self Concept | 1 | 2015 | 1029 | 0.360 |
Why?
|
| Hydronephrosis | 15 | 2011 | 275 | 0.350 |
Why?
|
| Kidney Pelvis | 4 | 2017 | 180 | 0.350 |
Why?
|
| Hypospadias | 8 | 2001 | 92 | 0.350 |
Why?
|
| Male | 159 | 2022 | 351080 | 0.340 |
Why?
|
| Urinary Tract Infections | 14 | 2017 | 780 | 0.340 |
Why?
|
| Infant, Newborn | 52 | 2018 | 24645 | 0.340 |
Why?
|
| Pediatrics | 4 | 2015 | 3553 | 0.340 |
Why?
|
| Intestine, Small | 1 | 2014 | 1230 | 0.320 |
Why?
|
| Cholinergic Antagonists | 4 | 2003 | 143 | 0.320 |
Why?
|
| Patient Satisfaction | 2 | 2022 | 3396 | 0.320 |
Why?
|
| Fetus | 3 | 2012 | 1836 | 0.310 |
Why?
|
| Urethral Stricture | 3 | 2017 | 58 | 0.310 |
Why?
|
| Tissue Engineering | 3 | 2014 | 1851 | 0.310 |
Why?
|
| Pressure | 6 | 2018 | 1240 | 0.300 |
Why?
|
| Guidelines as Topic | 1 | 2013 | 1420 | 0.300 |
Why?
|
| Toilet Training | 2 | 2019 | 19 | 0.300 |
Why?
|
| Patient Compliance | 4 | 2015 | 2753 | 0.290 |
Why?
|
| Fetal Diseases | 2 | 2011 | 898 | 0.290 |
Why?
|
| Enuresis | 4 | 2006 | 49 | 0.290 |
Why?
|
| Consensus | 6 | 2017 | 2744 | 0.280 |
Why?
|
| Bladder Exstrophy | 4 | 2014 | 92 | 0.280 |
Why?
|
| Testis | 7 | 2015 | 811 | 0.280 |
Why?
|
| Female | 128 | 2022 | 377328 | 0.280 |
Why?
|
| Bulbourethral Glands | 1 | 2004 | 7 | 0.270 |
Why?
|
| Spina Bifida Occulta | 4 | 2000 | 33 | 0.270 |
Why?
|
| Sacrum | 5 | 2012 | 304 | 0.260 |
Why?
|
| Patient Education as Topic | 1 | 2015 | 2341 | 0.260 |
Why?
|
| Urinary Diversion | 10 | 2003 | 140 | 0.260 |
Why?
|
| Postoperative Complications | 20 | 2011 | 15097 | 0.260 |
Why?
|
| Genital Diseases, Male | 1 | 2004 | 85 | 0.250 |
Why?
|
| Adaptation, Psychological | 1 | 2015 | 2544 | 0.250 |
Why?
|
| Muscle, Smooth | 5 | 2015 | 954 | 0.250 |
Why?
|
| Adolescent Behavior | 1 | 2012 | 1168 | 0.240 |
Why?
|
| Ureteral Neoplasms | 1 | 2003 | 89 | 0.230 |
Why?
|
| Intestinal Mucosa | 1 | 2014 | 3062 | 0.230 |
Why?
|
| Polyps | 2 | 2003 | 182 | 0.230 |
Why?
|
| Meningocele | 3 | 2016 | 43 | 0.230 |
Why?
|
| Guideline Adherence | 1 | 2013 | 2333 | 0.220 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2010 | 870 | 0.220 |
Why?
|
| Periodicals as Topic | 1 | 2013 | 1407 | 0.220 |
Why?
|
| Pedigree | 8 | 2020 | 4722 | 0.220 |
Why?
|
| Reproducibility of Results | 9 | 2022 | 19497 | 0.210 |
Why?
|
| Electromyography | 18 | 2020 | 1379 | 0.210 |
Why?
|
| Ureterostomy | 1 | 2000 | 18 | 0.200 |
Why?
|
| Cystostomy | 1 | 2000 | 27 | 0.200 |
Why?
|
| Urinary Bladder Neck Obstruction | 2 | 2000 | 84 | 0.200 |
Why?
|
| Clinical Protocols | 2 | 2016 | 1472 | 0.200 |
Why?
|
| Retrospective Studies | 35 | 2022 | 72253 | 0.200 |
Why?
|
| Urologic Surgical Procedures, Male | 3 | 2017 | 90 | 0.200 |
Why?
|
| Spasm | 1 | 2000 | 106 | 0.190 |
Why?
|
| Ketorolac | 1 | 2000 | 69 | 0.190 |
Why?
|
| Cysts | 2 | 2004 | 638 | 0.190 |
Why?
|
| Young Adult | 14 | 2022 | 56155 | 0.190 |
Why?
|
| Video Recording | 3 | 2015 | 949 | 0.180 |
Why?
|
| Solanaceous Alkaloids | 1 | 2018 | 3 | 0.170 |
Why?
|
| Fraser Syndrome | 1 | 2018 | 5 | 0.170 |
Why?
|
| Eye Abnormalities | 1 | 2020 | 219 | 0.170 |
Why?
|
| Orchiopexy | 1 | 2017 | 14 | 0.170 |
Why?
|
| Fatty Acids, Volatile | 1 | 2018 | 95 | 0.170 |
Why?
|
| Sacrococcygeal Region | 2 | 2016 | 53 | 0.170 |
Why?
|
| Parasympatholytics | 3 | 1994 | 92 | 0.160 |
Why?
|
| Follow-Up Studies | 31 | 2019 | 39285 | 0.160 |
Why?
|
| Urethral Obstruction | 1 | 1997 | 53 | 0.160 |
Why?
|
| Rheology | 1 | 2018 | 355 | 0.160 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2018 | 176 | 0.160 |
Why?
|
| Genetic Linkage | 3 | 2012 | 2516 | 0.150 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2019 | 265 | 0.150 |
Why?
|
| Urinary Reservoirs, Continent | 4 | 1998 | 30 | 0.150 |
Why?
|
| Cystoscopy | 6 | 2011 | 136 | 0.150 |
Why?
|
| Receptors, Nicotinic | 1 | 2019 | 491 | 0.150 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 1 | 2018 | 148 | 0.150 |
Why?
|
| Mutation | 5 | 2020 | 29441 | 0.150 |
Why?
|
| Forkhead Transcription Factors | 2 | 2020 | 1621 | 0.150 |
Why?
|
| Diurnal Enuresis | 1 | 2015 | 3 | 0.140 |
Why?
|
| Urinary Incontinence, Urge | 3 | 2015 | 37 | 0.140 |
Why?
|
| Kidney Diseases | 7 | 2012 | 2128 | 0.140 |
Why?
|
| Societies, Medical | 4 | 2015 | 3769 | 0.140 |
Why?
|
| Muscle Weakness | 1 | 2018 | 405 | 0.140 |
Why?
|
| Sports | 1 | 2021 | 651 | 0.130 |
Why?
|
| Urinary Tract Physiological Phenomena | 1 | 2014 | 10 | 0.130 |
Why?
|
| Stomach | 4 | 2000 | 671 | 0.130 |
Why?
|
| Disease Management | 2 | 2016 | 2534 | 0.130 |
Why?
|
| Age Factors | 7 | 2015 | 18789 | 0.130 |
Why?
|
| Predictive Value of Tests | 5 | 2015 | 15258 | 0.130 |
Why?
|
| Tretinoin | 1 | 2017 | 530 | 0.130 |
Why?
|
| Sperm Motility | 1 | 2015 | 254 | 0.120 |
Why?
|
| Self Care | 4 | 2012 | 804 | 0.120 |
Why?
|
| Abnormalities, Multiple | 4 | 2016 | 1385 | 0.120 |
Why?
|
| Social Participation | 1 | 2015 | 161 | 0.120 |
Why?
|
| Spinal Cord Injuries | 4 | 2008 | 987 | 0.120 |
Why?
|
| Intestinal Diseases | 1 | 2017 | 506 | 0.120 |
Why?
|
| Pilot Projects | 2 | 2016 | 8043 | 0.120 |
Why?
|
| Semen Analysis | 1 | 2015 | 226 | 0.120 |
Why?
|
| Treatment Outcome | 21 | 2016 | 62186 | 0.120 |
Why?
|
| Cryptorchidism | 3 | 1999 | 123 | 0.120 |
Why?
|
| T-Box Domain Proteins | 1 | 2015 | 472 | 0.120 |
Why?
|
| Anal Canal | 2 | 2012 | 344 | 0.110 |
Why?
|
| Urinary Calculi | 3 | 2001 | 80 | 0.110 |
Why?
|
| Social Adjustment | 1 | 2015 | 638 | 0.110 |
Why?
|
| Genes, Dominant | 1 | 2015 | 904 | 0.110 |
Why?
|
| Ureterocele | 3 | 2001 | 30 | 0.110 |
Why?
|
| Parents | 2 | 2022 | 3160 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2012 | 418 | 0.100 |
Why?
|
| Caregivers | 1 | 2022 | 1905 | 0.100 |
Why?
|
| Technetium Tc 99m Dimercaptosuccinic Acid | 3 | 2000 | 79 | 0.100 |
Why?
|
| Genes, X-Linked | 1 | 2011 | 135 | 0.100 |
Why?
|
| Time Factors | 16 | 2016 | 41082 | 0.100 |
Why?
|
| Enema | 1 | 2011 | 138 | 0.100 |
Why?
|
| Pain | 3 | 2020 | 4662 | 0.100 |
Why?
|
| Administration, Intravesical | 2 | 2004 | 70 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 4 | 2017 | 7480 | 0.100 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 1991 | 180 | 0.100 |
Why?
|
| Cross-Sectional Studies | 5 | 2021 | 23281 | 0.100 |
Why?
|
| Rectum | 2 | 2012 | 887 | 0.100 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2000 | 2266 | 0.090 |
Why?
|
| Death, Sudden | 1 | 2012 | 312 | 0.090 |
Why?
|
| Infant Care | 1 | 2011 | 188 | 0.090 |
Why?
|
| Mutation, Missense | 2 | 2018 | 2500 | 0.090 |
Why?
|
| Muscarinic Antagonists | 3 | 2015 | 131 | 0.090 |
Why?
|
| Kidney Calices | 1 | 2009 | 21 | 0.090 |
Why?
|
| Testicular Hydrocele | 1 | 2008 | 28 | 0.090 |
Why?
|
| Adult | 42 | 2021 | 212128 | 0.090 |
Why?
|
| Prognosis | 6 | 2019 | 29167 | 0.090 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2021 | 8602 | 0.090 |
Why?
|
| Rupture, Spontaneous | 2 | 2004 | 355 | 0.090 |
Why?
|
| Spermatic Cord Torsion | 2 | 2005 | 75 | 0.090 |
Why?
|
| Neurologic Examination | 5 | 1997 | 957 | 0.090 |
Why?
|
| Disease Progression | 3 | 2017 | 13302 | 0.090 |
Why?
|
| Repressor Proteins | 1 | 2020 | 3086 | 0.090 |
Why?
|
| Urachus | 2 | 1998 | 18 | 0.090 |
Why?
|
| International Cooperation | 1 | 2015 | 1420 | 0.090 |
Why?
|
| Rats | 5 | 2021 | 25090 | 0.080 |
Why?
|
| Urolithiasis | 1 | 2009 | 116 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2012 | 15584 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2009 | 412 | 0.080 |
Why?
|
| Combined Modality Therapy | 5 | 2018 | 8912 | 0.080 |
Why?
|
| Nomograms | 1 | 2009 | 234 | 0.080 |
Why?
|
| Kidney Neoplasms | 2 | 2003 | 4041 | 0.080 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 3458 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2018 | 3803 | 0.080 |
Why?
|
| Eosinophilia | 1 | 1991 | 513 | 0.080 |
Why?
|
| Sperm Count | 1 | 2007 | 226 | 0.080 |
Why?
|
| Physical Examination | 3 | 2012 | 1243 | 0.080 |
Why?
|
| Risk Factors | 9 | 2021 | 70705 | 0.070 |
Why?
|
| Balanitis | 1 | 2005 | 3 | 0.070 |
Why?
|
| Creatinine | 1 | 2012 | 1902 | 0.070 |
Why?
|
| Laparoscopy | 3 | 2008 | 1990 | 0.070 |
Why?
|
| Remission, Spontaneous | 3 | 2009 | 390 | 0.070 |
Why?
|
| Choristoma | 2 | 1998 | 217 | 0.070 |
Why?
|
| Benchmarking | 1 | 2012 | 928 | 0.070 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 3009 | 0.070 |
Why?
|
| Testicular Diseases | 1 | 2005 | 71 | 0.070 |
Why?
|
| Endoscopy | 3 | 2017 | 1754 | 0.070 |
Why?
|
| Anxiety | 1 | 2020 | 3898 | 0.070 |
Why?
|
| Scrotum | 3 | 2005 | 119 | 0.070 |
Why?
|
| Feasibility Studies | 1 | 2015 | 4916 | 0.070 |
Why?
|
| Sensitivity and Specificity | 4 | 2018 | 14877 | 0.070 |
Why?
|
| Ultrasonography | 7 | 2022 | 5943 | 0.070 |
Why?
|
| Pyelonephritis | 4 | 1980 | 79 | 0.060 |
Why?
|
| Patient Care Team | 1 | 2016 | 2592 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2018 | 17395 | 0.060 |
Why?
|
| Sympathomimetics | 1 | 2003 | 60 | 0.060 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2011 | 2094 | 0.060 |
Why?
|
| Prostheses and Implants | 3 | 1991 | 1343 | 0.060 |
Why?
|
| Prosthesis Failure | 2 | 2008 | 1225 | 0.060 |
Why?
|
| Heterozygote | 2 | 2020 | 2791 | 0.060 |
Why?
|
| Hepatocyte Nuclear Factor 3-gamma | 1 | 2022 | 9 | 0.060 |
Why?
|
| Teratoma | 1 | 2006 | 388 | 0.060 |
Why?
|
| Microsurgery | 1 | 2008 | 812 | 0.060 |
Why?
|
| Observer Variation | 1 | 2009 | 2680 | 0.060 |
Why?
|
| Evidence-Based Medicine | 2 | 2012 | 3701 | 0.060 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2022 | 70 | 0.060 |
Why?
|
| Radiography | 13 | 1997 | 6994 | 0.060 |
Why?
|
| Motor Neurons | 5 | 1995 | 815 | 0.060 |
Why?
|
| Spinal Cord Diseases | 2 | 1988 | 295 | 0.060 |
Why?
|
| Lipoma | 2 | 1997 | 335 | 0.060 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 9785 | 0.060 |
Why?
|
| Spinal Cord Neoplasms | 2 | 1997 | 277 | 0.060 |
Why?
|
| Prosthesis Design | 2 | 2008 | 2144 | 0.060 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 5977 | 0.050 |
Why?
|
| Circumcision, Male | 2 | 2017 | 150 | 0.050 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 18345 | 0.050 |
Why?
|
| Replantation | 3 | 1980 | 149 | 0.050 |
Why?
|
| Reference Standards | 2 | 2015 | 997 | 0.050 |
Why?
|
| Lithotripsy | 1 | 2001 | 140 | 0.050 |
Why?
|
| Rhabdomyosarcoma | 2 | 1996 | 381 | 0.050 |
Why?
|
| Amphibian Proteins | 1 | 2020 | 37 | 0.050 |
Why?
|
| Sex Factors | 4 | 2012 | 10651 | 0.050 |
Why?
|
| Decision Support Techniques | 1 | 2011 | 2038 | 0.050 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2003 | 643 | 0.050 |
Why?
|
| Arabs | 1 | 2021 | 130 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2020 | 12047 | 0.050 |
Why?
|
| Animals | 10 | 2021 | 170733 | 0.050 |
Why?
|
| Incidence | 6 | 2018 | 20596 | 0.050 |
Why?
|
| Radiopharmaceuticals | 3 | 2000 | 2731 | 0.050 |
Why?
|
| Home Nursing | 2 | 1998 | 92 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 2 | 2018 | 7045 | 0.050 |
Why?
|
| Epispadias | 1 | 1999 | 15 | 0.050 |
Why?
|
| Analysis of Variance | 4 | 2012 | 6531 | 0.050 |
Why?
|
| MicroRNAs | 1 | 2016 | 3673 | 0.050 |
Why?
|
| Umbilical Arteries | 2 | 1978 | 68 | 0.050 |
Why?
|
| Reoperation | 6 | 2009 | 4174 | 0.050 |
Why?
|
| Digestive System | 1 | 2000 | 267 | 0.050 |
Why?
|
| Larva | 1 | 2020 | 515 | 0.040 |
Why?
|
| Disorders of Sex Development | 1 | 1999 | 122 | 0.040 |
Why?
|
| Phenotype | 4 | 2020 | 16373 | 0.040 |
Why?
|
| Electric Stimulation Therapy | 2 | 2013 | 624 | 0.040 |
Why?
|
| Genetic Counseling | 2 | 1979 | 582 | 0.040 |
Why?
|
| Chondrocytes | 1 | 2003 | 771 | 0.040 |
Why?
|
| Xenopus | 1 | 2020 | 765 | 0.040 |
Why?
|
| Electrophysiology | 4 | 1997 | 1331 | 0.040 |
Why?
|
| Hospitals, Pediatric | 4 | 2017 | 1780 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2017 | 23975 | 0.040 |
Why?
|
| Gestational Age | 1 | 2006 | 3414 | 0.040 |
Why?
|
| Urogenital System | 1 | 2018 | 84 | 0.040 |
Why?
|
| Severity of Illness Index | 5 | 2015 | 16011 | 0.040 |
Why?
|
| Amino Acid Substitution | 2 | 2018 | 1834 | 0.040 |
Why?
|
| DNA | 2 | 2003 | 7159 | 0.040 |
Why?
|
| Vaginal Diseases | 1 | 1998 | 96 | 0.040 |
Why?
|
| Umbilical Cord | 1 | 1978 | 160 | 0.040 |
Why?
|
| Prospective Studies | 7 | 2020 | 51182 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2017 | 34394 | 0.040 |
Why?
|
| Kyphosis | 1 | 1998 | 209 | 0.040 |
Why?
|
| Prenatal Care | 1 | 2003 | 1017 | 0.040 |
Why?
|
| Methods | 5 | 1990 | 1174 | 0.040 |
Why?
|
| Exons | 2 | 2018 | 2476 | 0.040 |
Why?
|
| Nervous System | 1 | 2000 | 563 | 0.040 |
Why?
|
| Reflex, Abnormal | 2 | 1994 | 85 | 0.040 |
Why?
|
| Vaginal Neoplasms | 1 | 1996 | 108 | 0.040 |
Why?
|
| Cystitis | 3 | 1994 | 88 | 0.040 |
Why?
|
| Ureteral Diseases | 2 | 1989 | 65 | 0.040 |
Why?
|
| Ileum | 3 | 1989 | 564 | 0.040 |
Why?
|
| Consanguinity | 1 | 2018 | 468 | 0.040 |
Why?
|
| Chromosome Mapping | 3 | 2011 | 4824 | 0.040 |
Why?
|
| Genome, Human | 1 | 2009 | 4471 | 0.040 |
Why?
|
| Lumbosacral Plexus | 1 | 1995 | 54 | 0.040 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2015 | 168 | 0.040 |
Why?
|
| Risk Assessment | 3 | 2018 | 23510 | 0.030 |
Why?
|
| Perineum | 1 | 1996 | 202 | 0.030 |
Why?
|
| Mice | 6 | 2020 | 80997 | 0.030 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2015 | 314 | 0.030 |
Why?
|
| Urinary Fistula | 1 | 1994 | 42 | 0.030 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2002 | 1595 | 0.030 |
Why?
|
| Nephrology | 1 | 2017 | 240 | 0.030 |
Why?
|
| Cutaneous Fistula | 1 | 1994 | 84 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 2018 | 1247 | 0.030 |
Why?
|
| Botulinum Toxins | 1 | 2015 | 187 | 0.030 |
Why?
|
| Muscular Dystrophies | 1 | 1996 | 390 | 0.030 |
Why?
|
| Hypertrophy | 2 | 2007 | 576 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2013 | 20397 | 0.030 |
Why?
|
| Urinary Incontinence, Stress | 1 | 2015 | 172 | 0.030 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2018 | 848 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2003 | 2960 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2018 | 2926 | 0.030 |
Why?
|
| Prevalence | 2 | 2021 | 14869 | 0.030 |
Why?
|
| China | 1 | 2019 | 2272 | 0.030 |
Why?
|
| Athletes | 1 | 2021 | 1044 | 0.030 |
Why?
|
| Homozygote | 1 | 2018 | 1844 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 3862 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2018 | 2366 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2018 | 1097 | 0.030 |
Why?
|
| Boston | 4 | 2017 | 9400 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2015 | 944 | 0.030 |
Why?
|
| Behavior Therapy | 2 | 2013 | 869 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2020 | 15263 | 0.030 |
Why?
|
| Laxatives | 1 | 2013 | 80 | 0.030 |
Why?
|
| Prenatal Diagnosis | 2 | 2017 | 1162 | 0.030 |
Why?
|
| Nervous System Diseases | 2 | 1996 | 1642 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 2015 | 995 | 0.030 |
Why?
|
| Cicatrix | 2 | 2012 | 693 | 0.030 |
Why?
|
| Diagnosis, Differential | 5 | 2011 | 13267 | 0.030 |
Why?
|
| Rhombencephalon | 1 | 2012 | 83 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2018 | 2860 | 0.030 |
Why?
|
| Clinical Alarms | 1 | 2012 | 44 | 0.030 |
Why?
|
| Chi-Square Distribution | 2 | 2011 | 3565 | 0.030 |
Why?
|
| Ostomy | 1 | 2011 | 31 | 0.030 |
Why?
|
| Surgical Stomas | 1 | 2011 | 45 | 0.030 |
Why?
|
| Sleep Apnea, Central | 1 | 2012 | 81 | 0.030 |
Why?
|
| Surgical Wound Dehiscence | 1 | 1992 | 215 | 0.030 |
Why?
|
| Age Distribution | 1 | 1997 | 2927 | 0.030 |
Why?
|
| Models, Animal | 1 | 2018 | 2219 | 0.030 |
Why?
|
| Recurrence | 4 | 2011 | 8269 | 0.020 |
Why?
|
| Ultrasonography, Doppler | 1 | 2013 | 462 | 0.020 |
Why?
|
| Prolapse | 1 | 1990 | 59 | 0.020 |
Why?
|
| Genital Neoplasms, Male | 1 | 1990 | 76 | 0.020 |
Why?
|
| Infant, Newborn, Diseases | 1 | 1975 | 553 | 0.020 |
Why?
|
| Constriction, Pathologic | 2 | 2011 | 1034 | 0.020 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2012 | 201 | 0.020 |
Why?
|
| Electrolytes | 1 | 2011 | 279 | 0.020 |
Why?
|
| Logistic Models | 2 | 2015 | 13594 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2009 | 11907 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2003 | 4688 | 0.020 |
Why?
|
| Catheterization | 1 | 1975 | 1453 | 0.020 |
Why?
|
| Mesencephalon | 1 | 2012 | 322 | 0.020 |
Why?
|
| Alleles | 1 | 2021 | 7095 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 3 | 1989 | 1742 | 0.020 |
Why?
|
| Organ Size | 1 | 2015 | 2313 | 0.020 |
Why?
|
| Family | 1 | 2020 | 3097 | 0.020 |
Why?
|
| Cohort Studies | 4 | 2015 | 39804 | 0.020 |
Why?
|
| Contrast Media | 1 | 2022 | 5271 | 0.020 |
Why?
|
| Dilatation, Pathologic | 4 | 1989 | 516 | 0.020 |
Why?
|
| Lod Score | 1 | 2009 | 618 | 0.020 |
Why?
|
| Base Sequence | 2 | 2015 | 13316 | 0.020 |
Why?
|
| Reconstructive Surgical Procedures | 1 | 2001 | 2126 | 0.020 |
Why?
|
| Sodium Chloride | 1 | 2011 | 637 | 0.020 |
Why?
|
| Netherlands | 1 | 2013 | 2085 | 0.020 |
Why?
|
| Risk | 4 | 1984 | 9772 | 0.020 |
Why?
|
| Reflex | 1 | 1989 | 352 | 0.020 |
Why?
|
| Medical History Taking | 1 | 2012 | 801 | 0.020 |
Why?
|
| Protein Binding | 1 | 2020 | 9660 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 2815 | 0.020 |
Why?
|
| Hematologic Diseases | 1 | 2011 | 494 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2016 | 1899 | 0.020 |
Why?
|
| Siblings | 1 | 2011 | 814 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2018 | 5535 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2015 | 18734 | 0.020 |
Why?
|
| Pregnancy | 3 | 2003 | 27180 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2017 | 2950 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2004 | 8094 | 0.020 |
Why?
|
| Respiratory Tract Diseases | 1 | 2012 | 691 | 0.020 |
Why?
|
| Radionuclide Imaging | 3 | 2000 | 2034 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2020 | 21789 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2000 | 11900 | 0.020 |
Why?
|
| Ischemia | 1 | 1995 | 1939 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2015 | 4321 | 0.020 |
Why?
|
| Surgical Flaps | 1 | 1994 | 1634 | 0.020 |
Why?
|
| Psychometrics | 1 | 2015 | 2964 | 0.020 |
Why?
|
| Scoliosis | 1 | 2012 | 692 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 2011 | 1180 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2018 | 14237 | 0.020 |
Why?
|
| Walking | 1 | 1992 | 1102 | 0.020 |
Why?
|
| Thymine | 1 | 2004 | 60 | 0.020 |
Why?
|
| Postoperative Period | 2 | 2006 | 1854 | 0.020 |
Why?
|
| Infertility, Male | 1 | 2007 | 408 | 0.020 |
Why?
|
| Sertoli Cell Tumor | 1 | 1983 | 25 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2015 | 4910 | 0.020 |
Why?
|
| Kidney Tubules | 1 | 2006 | 494 | 0.020 |
Why?
|
| Congenital Abnormalities | 2 | 1998 | 697 | 0.020 |
Why?
|
| Jejunum | 1 | 1985 | 503 | 0.020 |
Why?
|
| Technetium Tc 99m Pentetate | 1 | 1983 | 69 | 0.010 |
Why?
|
| Guanine | 1 | 2004 | 282 | 0.010 |
Why?
|
| Cytosine | 1 | 2004 | 225 | 0.010 |
Why?
|
| Kidney Glomerulus | 1 | 2006 | 691 | 0.010 |
Why?
|
| Pentetic Acid | 1 | 1983 | 220 | 0.010 |
Why?
|
| Adrenal Hyperplasia, Congenital | 1 | 1983 | 101 | 0.010 |
Why?
|
| Technetium | 1 | 1983 | 355 | 0.010 |
Why?
|
| Proline | 1 | 2004 | 440 | 0.010 |
Why?
|
| Genitalia, Female | 1 | 1983 | 142 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2003 | 256 | 0.010 |
Why?
|
| Algorithms | 2 | 2015 | 13669 | 0.010 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2002 | 169 | 0.010 |
Why?
|
| Urothelium | 1 | 2004 | 288 | 0.010 |
Why?
|
| Retreatment | 1 | 2003 | 628 | 0.010 |
Why?
|
| Alanine | 1 | 2004 | 597 | 0.010 |
Why?
|
| Introns | 1 | 2004 | 1014 | 0.010 |
Why?
|
| Postoperative Care | 2 | 1999 | 1512 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 2936 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 11766 | 0.010 |
Why?
|
| Muscle Contraction | 1 | 1986 | 1248 | 0.010 |
Why?
|
| Linear Models | 2 | 2005 | 5980 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2018 | 5153 | 0.010 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2003 | 634 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 1999 | 12425 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 2003 | 726 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2003 | 739 | 0.010 |
Why?
|
| Cardiomegaly | 1 | 2003 | 645 | 0.010 |
Why?
|
| Hyperplasia | 1 | 2002 | 1173 | 0.010 |
Why?
|
| Wilms Tumor | 1 | 1981 | 339 | 0.010 |
Why?
|
| Gastrointestinal Motility | 1 | 2000 | 210 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 1999 | 293 | 0.010 |
Why?
|
| Heart Diseases | 1 | 2012 | 2763 | 0.010 |
Why?
|